CN108976114A — 一种格隆溴铵中间体2-环戊基-2-羟基苯乙酸的纯化方法
Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2018-12-11 · 7y expired
What this patent protects
本发明公开了格隆溴铵中间体2‑环戊基‑2‑羟基苯乙酸的纯化方法,包括:(1)将2‑环戊基‑2‑羟基苯乙酸粗品在乙醇和水的混合溶剂中加热溶解后,冷却析晶,过滤得固体;(2)将步骤(1)得到的固体在甲苯中加热溶解后,冷却析晶,过滤得2‑环戊基‑2‑羟基苯乙酸固体。该方法能够有效地除去各种杂质,显著提高了产品的纯度,HPLC纯度大于98.0%,并最大限度的降低了2‑环戊基‑2‑羟基苯乙酸的损失,提高了收率,适合工业化生产。
USPTO Abstract
本发明公开了格隆溴铵中间体2‑环戊基‑2‑羟基苯乙酸的纯化方法,包括:(1)将2‑环戊基‑2‑羟基苯乙酸粗品在乙醇和水的混合溶剂中加热溶解后,冷却析晶,过滤得固体;(2)将步骤(1)得到的固体在甲苯中加热溶解后,冷却析晶,过滤得2‑环戊基‑2‑羟基苯乙酸固体。该方法能够有效地除去各种杂质,显著提高了产品的纯度,HPLC纯度大于98.0%,并最大限度的降低了2‑环戊基‑2‑羟基苯乙酸的损失,提高了收率,适合工业化生产。
Drugs covered by this patent
- Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.